8-KThe WireRoutine
Bylaw Amendment
Filed May 11, 2023 · 3y ago · Accession 0000950170-23-021359
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Viking Therapeutics, Inc.
- Ticker
- VKTX
- CIK
- 1607678
- Form type
- 8-K
- Filing date
- May 11, 2023
- Report date
- May 9, 2023
- Document
- vktx-20230509.htm
- Size
- 462 KB